Pulse Biosciences Inc
Research Pulse Biosciences Inc (PLSE) on Bullrun: market cap USD 1.99B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPLSE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 1.99B
- Financial periodFY2025
- RevenueUSD 350.00K
- Net income-USD 72.78M
- Free cash flow-USD 54.44M
- Gross margin-54.0%
Valuation Snapshot
latest market cap is USD 1.99B.
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle;
Frequently asked questions
What is Pulse Biosciences Inc's market cap?
Pulse Biosciences Inc's market capitalization is USD 1.99B.
What does Pulse Biosciences Inc do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting;